pre-IPO PHARMA

cumulus-oncology PRESS RELEASE ARCHIVE

Feb 22, 2022

Cumulus Oncology Secures £4.1m ($5.6m) Investment Led by Eos Advisory


May 17, 2019

Ligand Licenses VER250840 to Cumulus Oncology


Google Analytics Alternative